Skip to content

A Randomized Controlled Trial Comparing AI-Driven Versus Nurse-Guided Expressive Writing for Psychological Well-being in Cancer Patients

A Randomized Controlled Trial Comparing AI-Driven Versus Nurse-Guided Expressive Writing for Psychological Well-being in Cancer Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089455
Enrollment
Unknown
Registered
2024-09-09
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

The AI-driven expressive writing group:The AI-EW group interacted with a therapeutic chatbot, accessed through the popular Chinese instant messaging platform QQ. This chatbot, powered by the Google AI
Mordechay, Nir, & Eviatar, 2019
Park et al., 2021).
The nurse-guided expressive writing Group (NG-EW):Participants in the NG-EW group, similar to the AI-EW group, utilized the QQ software. This group was facilitated by oncology nurses who completed a c
understanding emotional distress in

Sponsors

Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) aged 18~60 years; (2) having a diagnosis of any type of cancer; (3) completion of primary treatments such as surgery, chemotherapy, or radiation therapy, and being in the recovery phase without signs of relapse; (4) possessing sufficient literacy in Chinese to understand the study’s procedures and to express their thoughts and feelings through writing; (5) willingness and ability to engage in the expressive writing interventions via QQ, a Chinese real-time communication software.

Exclusion criteria

Exclusion criteria: (1) undergoing acute psychiatric treatment at the time of the study; (2) having a history of severe psychiatric disorders such as schizophrenia or bipolar disorder that could interfere with study procedures; (3) having cognitive impairments that preclude informed consent or understanding of the expressive writing instructions; (4) participation in another psychotherapy intervention or clinical trial that could potentially influence the outcomes of this study.

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire-9 (PHQ-9);Generalized Anxiety Disorder-7 (GAD-7);

Secondary

MeasureTime frame
Fear of Progression Questionnaire-Short Form (FoPQ-SF);Connor-Davidson Resilience Scale (CD-RISC);

Countries

China

Contacts

Public ContactXueling Yang

Southern Medical University

yhtyxl2006@126.com+86 186 6500 0250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026